251 related articles for article (PubMed ID: 37074377)
21. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.
Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F
Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Nomogram for Overall Survival in Early Stage Extranodal Natural Killer/T Cell Lymphoma Treated With High-Dose Radiotherapy.
Huang L; Wu Y; Wang Y; Xie Y; Wu F; Li S; Liang Z; Zhu X
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):289-295. PubMed ID: 32122775
[TBL] [Abstract][Full Text] [Related]
23. Dynamic Prediction of Survival for Sinonasal Extranodal Natural Killer/T-cell Lymphoma.
Wang T; Qiu Y; Shi L; Chen D; Chen X; Liu J; Liu T
Laryngoscope; 2023 Jul; 133(7):1645-1651. PubMed ID: 37294046
[TBL] [Abstract][Full Text] [Related]
24. Nomograms including the controlling nutritional status score in patients with hepatocellular carcinoma undergoing transarterial chemoembolisation for prediction survival: a retrospective analysis.
Chen Y; Xu WJ; Yang Y; Xin YJ; Zhang XY; Li X; Zhou X
Br J Nutr; 2022 Nov; 128(10):1966-1974. PubMed ID: 34881693
[TBL] [Abstract][Full Text] [Related]
25. Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10893-10909. PubMed ID: 37318591
[TBL] [Abstract][Full Text] [Related]
26. The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.
Li J; Li J; Zhong M; Zhou H; Yu B
Cancer Manag Res; 2021; 13():1541-1549. PubMed ID: 33623433
[TBL] [Abstract][Full Text] [Related]
27. Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
Chen SY; Yang Y; Qi SN; Wang Y; Hu C; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Qiao XY; Wang H; Li GF; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Shi M; Xu LM; Yuan ZY; Yahalom J; Tsang R; Song YQ; Zhu J; Su H; Li YX
Leukemia; 2021 Jan; 35(1):130-142. PubMed ID: 32152465
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Nutritional Index, Another Prognostic Factor for Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Yao N; Hou Q; Zhang S; Xiao H; Liang Y; Xu X; Guo R; Li H; Lan S; Si H; Cao J
Front Oncol; 2020; 10():877. PubMed ID: 32637354
[No Abstract] [Full Text] [Related]
30. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery.
Dang C; Wang M; Zhu F; Qin T; Qin R
Asian J Surg; 2022 Jun; 45(6):1237-1245. PubMed ID: 34493426
[TBL] [Abstract][Full Text] [Related]
31. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Li ZM; Xia Y; Huang JJ; Huang HQ; Xia ZJ; Lin TY; Li S; Cai XY; Wu-Xiao ZJ; Jiang WQ
PLoS One; 2013; 8(5):e64158. PubMed ID: 23724031
[TBL] [Abstract][Full Text] [Related]
32. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
34. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
35. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX
Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma.
Nakamura N; Kanemura N; Lee S; Fujita K; Morishita T; Takada E; Shibata Y; Kasahara S; Goto H; Fukuno K; Hara T; Yamada T; Sawada M; Tsurumi H; Shimizu M
Leuk Lymphoma; 2022 Jun; 63(6):1323-1330. PubMed ID: 34965828
[TBL] [Abstract][Full Text] [Related]
37. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
[TBL] [Abstract][Full Text] [Related]
38. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
[TBL] [Abstract][Full Text] [Related]
39. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ
Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Tian XP; Zhang YC; Lin NJ; Wang L; Li ZH; Guo HG; Ma SY; An MJ; Yang J; Hong YH; Wang XH; Zhou H; Li YJ; Rao HL; Li M; Hu SX; Lin TY; Li ZM; Huang H; Liang Y; Xia ZJ; Lv Y; Liu YY; Duan ZH; Chen QY; Wang JN; Cai J; Xie Y; Ong CK; Liu F; Liu YY; Yan Z; Huang L; Tao R; Li WY; Huang HQ; Cai QQ
Cell Rep Med; 2023 Feb; 4(2):100859. PubMed ID: 36812892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]